Efficacy and safety of nivolumab plus ipilimumab in gastrointestinal cancers: a systematic review and meta-analysis

Efficacy and safety of nivolumab plus ipilimumab in gastrointestinal cancers: a systematic review and meta-analysis

IntroductionGastrointestinal (GI) cancers represent a significant global health burden, and the need for more effective treatment options is exceptionally pressing. The present meta-analysis aimed to explore the efficacy and safety of the combination of nivolumab and ipilimumab in treating GI cancer...

Full description

Saved in:

Bibliographic Details
Main Authors:	Bowen Dai, Jiaping Jiang, Xiaoyu Yu, Haihua Zhan, Zhengchuan Hu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Oncology
Subjects:	nivolumab ipilimumab gastrointestinal cancer objective response rate efficacy meta-analysis
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1515992/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy and safety of first-line nivolumab plus ipilimumab treatment in elderly patients (aged ≥ 75 years) with non-small cell lung cancer
by: Satoshi Endo, et al.
Published: (2025-01-01)

Eosinophil is a predictor of severe immune-related adverse events induced by ipilimumab plus nivolumab therapy in patients with renal cell carcinoma: a retrospective multicenter cohort study
by: Yoshihiko Tasaki, et al.
Published: (2025-01-01)

Early detection of myocarditis caused by immune checkpoint inhibitor therapy with nivolumab and ipilimumab for advanced recurrent renal cell carcinoma
by: Maki Todo, et al.
Published: (2025-02-01)

Durable Clinical Benefit after Dual Checkpoint Inhibition and Single-agent Nivolumab Following Pembrolizumab Failure in Mismatch Repair-deficient Colon Cancer
by: Yat-Fung Chow, et al.
Published: (2023-10-01)

Case report: A severe myositis mimicking bulbar palsy after administration of immune checkpoint inhibitors
by: Philippe Rochigneux, et al.
Published: (2025-02-01)

MODERN TREATMENT OF METASTATIC MELANOMA: FROM STANDARDS TO AN INDIVIDUALIZED APPROACH IN REAL CLINICAL PRACTICE
by: N. V. Zhukova, et al.
Published: (2018-06-01)

Multifocal disseminated necrotizing leukoencephalopathy as severe central nervous system toxicity from nivolumab therapy for Hodgkin lymphoma: a case report
by: Hussein Algahtani, et al.
Published: (2025-01-01)

A case of eruptive keratoacanthomas and lichen planus secondary to nivolumab treatment for stage IV melanoma
by: Daniel S. Alicea, MS, et al.
Published: (2025-03-01)

Phase II trial of nab-paclitaxel plus ramucirumab in combination with nivolumab for unresectable advanced or recurrent gastric cancer after progression on first-line treatment including fluoropyrimidine, platinum, and anti-PD-1/PD-L1 antibody (PADDLE)
by: Hidekazu Hirano, et al.
Published: (2025-02-01)

Nationwide multi-centric prospective study for the identification of biomarkers to predict the treatment responses of nivolumab through comprehensive analyses of pretreatment plasma exosome mRNAs from head and neck cancer patients (BIONEXT study)
by: Kuniaki Sato, et al.
Published: (2025-01-01)

5-Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan as a Potential Standard for Second-line Therapy in Extrapulmonary Neuroendocrine Carcinomas
by: I-Wei Ho, et al.
Published: (2024-12-01)

Retinal Toxicity after Initial Administration of Nivolumab and Ipilimumab
by: Adnan Kilani, et al.
Published: (2023-01-01)

Hidradenitis suppurativa induced by ipilimumab and nivolumab: A rare association
by: Alexander D. Woods, MD, et al.
Published: (2025-03-01)

The efficacy and safety of indobufen in patients with ischemic cardiovascular or cerebrovascular diseases: systematic review and meta-analysis
by: Xiaolu Luo, et al.
Published: (2025-01-01)

Nivolumab and Ipilimumab Combination Immunotherapy for Patients with Metastatic Collecting Duct Carcinoma
by: Tetsuya Danno, et al.
Published: (2021-01-01)

Sitravatinib in combination with nivolumab plus ipilimumab in patients with advanced clear cell renal cell carcinoma: a phase 1 trial
by: Pavlos Msaouel, et al.
Published: (2025-01-01)

Meta-analysis of Efficacy and Safety of Fire Acupuncture in Treatment of Ganglion Cyst
by: Yanan LIU, et al.
Published: (2019-08-01)

Efficacy and safety of hydroxyurea therapy on patients with β-thalassemia: a systematic review and meta-analysis
by: Tianmin Huang, et al.
Published: (2025-01-01)

Efficacy and safety of pembrolizumab in patients with advanced endometrial cancer: a systematic review and meta-analysis
by: Biqiong Pan, et al.
Published: (2025-02-01)

Network meta-analysis of efficacy and safety of drugs for the treatment of moderate to severe ulcerative colitis
by: Wenkai Zhang, et al.
Published: (2025-01-01)

Immune checkpoint inhibitors in cancer patients with autoimmune disease: Safety and efficacy
by: Jiayuan Le, et al.
Published: (2025-12-01)

Efficacy and safety of tripterygium glycosides combined with ACEI/ARB on diabetic nephropathy: a meta-analysis
by: Zhuan’E. Yao, et al.
Published: (2025-01-01)

Efficacy and Safety of CART Cell Therapy in Aggressive B‐Cell Lymphomas Involving the Gastrointestinal Tract
by: Lixia Ma, et al.
Published: (2025-01-01)

Pathologic Complete Response to Neoadjuvant Nivolumab/Ipilimumab in a Patient with Metastatic Renal Cell Carcinoma
by: Taylor C. Peak, et al.
Published: (2020-01-01)

Tumor del estroma gastrointestinal
by: Rene Santiago Borges Sandrino, et al.
Published: (2021-04-01)

Lambert-Eaton Myasthenic Syndrome Secondary to Nivolumab and Ipilimumab in a Patient with Small-Cell Lung Cancer
by: Kavita Agrawal, et al.
Published: (2019-01-01)

Gastrointestinal System Involvement in COVID
by: Amnuay Kleebayoon, et al.
Published: (2023-06-01)

The Association Between Serum Gamma‐Glutamyl Transferase and Gastrointestinal Cancer Risk: A Systematic Review and Meta‐Analysis
by: Alireza Ramandi, et al.
Published: (2025-01-01)

Gastrointestinal stromal tumors
by: A. P. Seryakov
Published: (2010-08-01)

Systematic review and bayesian network meta-analysis: comparative efficacy and safety of six commonly used biologic therapies for moderate-to-severe Crohn’s disease
by: Haohang Su, et al.
Published: (2025-01-01)

Selected allergic diseases of the gastrointestinal tract
by: Andrzej Kuźmiński, et al.
Published: (2019-09-01)

Kajian meta analisis: Effect size hubungan self efficacy terhadap prestasi belajar
by: Bettri Yustinaningrum, et al.
Published: (2024-12-01)

The prevalence of gastrointestinal parasites of turkeys (meleagris yallopavo)
by: Ferda Sevinç, et al.

Systemic sclerosis and the gastrointestinal tract
by: Irena Walecka
Published: (2017-09-01)

Efficacy and safety of intermittent fasting for type 2 diabetes mellitus: A systematic review and meta-analysis of randomized trials
by: Joshua Chadwick, et al.
Published: (2025-01-01)

Efficacy and safety of neoadjuvant bevacizumab plus chemotherapy in locally advanced gastric cancer patients: a retrospective, comparative study
by: Bin Yin, et al.
Published: (2025-01-01)

Robotic surgery in gastrointestinal surgery: History, current status, and challenges
by: Yu Liu, et al.
Published: (2024-01-01)

Diagnóstico incidental de un tumor del estroma gastrointestinal
by: Javier Cruz Rodríguez, et al.
Published: (2017-12-01)

Prevalance of Gastrointestinal Protozoa of Cats in Animal Hospital and Animal Clinic in Surabaya
by: Amara Lintang Pagati, et al.
Published: (2019-12-01)

Four-year clinical update and treatment switching-adjusted outcomes with first-line nivolumab plus ipilimumab with chemotherapy for metastatic non-small cell lung cancer in the CheckMate 9LA randomized trial
by: Enriqueta Felip, et al.
Published: (2024-02-01)